India's drug regulator had approved on December 28 Covovax for restricted use in emergency situations in adults, and on March 9 it was approved for 12-17 age group subject to certain conditions.
Posted from: 0001-01-01 00:00:00Z2022-04-11 17:51:08Z[]this blog via Microsoft Power Automate.
